Patent · US Active

Tri-cycle compound and applications thereof

US11053260B2 · kind B2 · utility

1Cited by

0References

18Claims

0Family size

Assignee

FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. · CN

Inventors

Haiying He · Shanghai, CN
Jing Wang · Beijing, CN
Zhigan Jiang · Shanghai, CN
Yaxun YANG · Shanghai, CN
Peng Shao · Shanghai, CN
Chen ZHANG · Chengdu, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Feb 9, 2018
Grant date	Jul 6, 2021
Priority date	—
Expiry date	Feb 12, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed in the present invention are a compound represented by formula (I), a tautomer thereof or a pharmaceutically acceptable salt, and applications thereof in the preparation of drugs for treating HBV-related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.